Physician

John Allen Piede, MD

According to 2025 Medicare claims, John Piede, MD (NPI: 1972782548) practices medical oncology in the Birmingham, AL market, with the plurality of this provider's patient population coming from Jefferson, AL. This provider's primary affiliated billing organization is BIRMINGHAM HEMATOLOGY ONCOLOGY ASSOC LLC (NPI: 1841216389; TIN: 522170293) and primary practice location at 35205-1202.

Piede's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 376 traditional Medicare patients, billed 152,761 HCPCS/CPT codes, and received $2,625,132 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,849 prescription claims across 282 beneficiaries totaling $4,922,973 in drug costs, led by Imbruvica (Ibrutinib). 2022 DME data shows 15 claims. Open Payments data shows 46 records totaling $887. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $3,689,130 to $2,625,132. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,871,331 to $4,922,973. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $22,239 to $1,055.